IQVIA (IQV) Financial Analysis & Valuation | Quarter Chart
IQVIA (IQV)
IQVPrice: $193.28
Fair Value: 🔒
🔒score
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, a... more
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research service... more
Description
Shares
| Market Cap | $32.26B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Ari Bousbib |
| IPO Date | 2013-05-09 | CAGR | 0.1% |
| Employees | 89,000 | Website | www.iqvia.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 1.1% | Total Yield | 1.1% |
IQV chart loading...
Fundamentals
Technicals
| Enterprise Value | $33.08B | P/E Ratio | 15.93 |
| Forward P/E | 13.62 | PEG Ratio | 1.6 |
| P/S Ratio | 2.12 | P/B Ratio | 5.72 |
| P/CF Ratio | 13.18 | P/FCF Ratio | 13.23 |
| EPS | $12.13 | EPS Growth 1Y | 9.95% |
| EPS Growth 3Y | 45.14% | EPS Growth 5Y | 282.46% |
| Revenue Growth 1Y | 7.32% | Gross Margin | 0.26% |
| Operating Margin | 0.14% | Profit Margin | 0.08% |
| ROE | 0.22% | ROA | 0.05% |
| ROCE | 0.11% | Current Ratio | 0.75 |
| Quick Ratio | 0.75 | Cash Ratio | 0.23 |
| Debt/Equity | 0.33 | Interest Coverage | 3.05 |
| Altman Z Score | 1.93 | Piotroski Score | 6 |